| Literature DB >> 31198521 |
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders, occurring in 5-10% women in reproductive ages. Despite a long history of studies on PCOS, its etiology is still unknown. Oxidative stress is now recognized to play a central role in the pathophysiology of many different disorders, including PCOS. Although intracellular reactive oxygen species (ROS) production and propagation are controlled by highly complex antioxidant enzymatic and non-enzymatic systems, understanding of mechanisms that oxidative stress is important to develop strategies for prevention and therapy of PCOS. This article reviews the literature data related to the mechanisms of oxidative stress in PCOS.Entities:
Keywords: Antioxidant; oxidative marker; oxidative stress; polycystic ovary syndrome; reactive oxygen species
Year: 2019 PMID: 31198521 PMCID: PMC6547785 DOI: 10.4103/ijpvm.IJPVM_576_17
Source DB: PubMed Journal: Int J Prev Med ISSN: 2008-7802
Oxidative stress markers in polycystic ovary syndrome (PCOS) patients
| Markers reflecting oxidative stress levels | Source | OS levels of PCOS patients compared with the normal |
|---|---|---|
| Malondialdehyde (MDA) | Serum; erythrocyte | Higher |
| Nitric oxide (NO) | Serum | Higher Similar |
| Advanced glycosylated end products (AGEs) | Serum | Higher |
| Xanthine oxidase (XO) | Serum | Higher |
Antioxidative stress markers in polycystic ovary syndrome (PCOS) patients
| Markers reflecting antioxidative stress levels | Source | OS levels of PCOS patients compared with the normal |
|---|---|---|
| Superoxide dismutase (SOD) | Serum; erythrocyte; and follicular fluid | Higher |
| Glutathione peroxidase (GPx) | Serum | Lower |
| Total antioxidant capacity (TAC) | Follicular fluid; serum | Higher |
| Vitamin E | Serum | Lower |
| Vitamin C | Serum | Lower |